Welcome to LookChem.com Sign In|Join Free
  • or
3-(BromoMethyl)-α,α,5-triMethyl-benzeneacetonitrile is an organic compound characterized by its unique molecular structure. It features a benzene ring with three methyl groups (CH3) attached to the α (alpha) and 5 positions, and a cyano group (CN) at the 2 position. The compound is further distinguished by a bromomethyl group (BrCH2) attached to the 3 position of the benzene ring. This chemical is primarily used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals due to its reactive functional groups, which can be further modified in chemical reactions. Its properties, such as reactivity and stability, make it a valuable building block in the creation of more complex molecules.

120512-36-9

Post Buying Request

120512-36-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

120512-36-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 120512-36-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,5,1 and 2 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 120512-36:
(8*1)+(7*2)+(6*0)+(5*5)+(4*1)+(3*2)+(2*3)+(1*6)=69
69 % 10 = 9
So 120512-36-9 is a valid CAS Registry Number.

120512-36-9Downstream Products

120512-36-9Relevant academic research and scientific papers

Preparation method of anastrozole derivatives

-

Paragraph 0033; 0035; 0036; 0060; 0063; 0064, (2018/10/19)

The invention discloses a preparation method of anastrozole derivatives, and belongs to the field of drug synthesis. The method has the advantages of reasonable process design, strong operability, mild reaction conditions and high yield and can realize in

Dual aromatase-sulfatase inhibitors based on the anastrozole template: Synthesis, in vitro SAR, molecular modelling and in vivo activity

Jackson, Toby,Woo, L. W. Lawrence,Trusselle, Melanie N.,Chander, Surinder K.,Purohit, Atul,Reed, Michael J.,Potter, Barry V. L.

, p. 2940 - 2952 (2008/04/02)

The synthesis and biological evaluation of a series of novel Dual Aromatase-Sulfatase Inhibitors (DASIs) are described. It is postulated that dual inhibition of the aromatase and steroid sulfatase enzymes, both responsible for the biosynthesis of oestrogens, will be beneficial in the treatment of hormone-dependent breast cancer. The compounds are based upon the Anastrozole aromatase inhibitor template which, while maintaining the haem ligating triazole moiety crucial for enzyme inhibition, was modified to include a phenol sulfamate ester motif, the pharmacophore for potent irreversible steroid sulfatase inhibition. Adaption of a synthetic route to Anastrozole was accomplished via selective radical bromination and substitution reactions to furnish a series of inhibitory aromatase pharmacophores. Linking these fragments to the phenol sulfamate ester moiety employed SN2, Heck and Mitsunobu reactions with phenolic precursors, from where the completed DASIs were achieved via sulfamoylation. In vitro, the lead compound, 11, had a high degree of potency against aromatase (IC50 3.5 nM), comparable with that of Anastrozole (IC50 1.5 nM) whereas, only moderate activity against steroid sulfatase was found. However, in vivo, 11 surprisingly exhibited potent dual inhibition. Compound 11 was modelled into the active site of a homology model of human aromatase and the X-ray crystal structure of steroid sulfatase. This journal is The Royal Society of Chemistry.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 120512-36-9